DM was found to be a negative predictive factor in patients undergoing treatment with antiangiogenic agents, while in those patients treated with anti-EGFR, DM was a positive predictive factor, though without reaching statistical significance (p = 0.07363 and p = 0.06219, respectively). The gene discussed is EGFR; the disease is diabetes mellitus.